Literature DB >> 11037190

Moyamoya disease.

M Fukui1, S Kono, K Sueishi, K Ikezaki.   

Abstract

Moyamoya disease is a specific chronic cerebrovascular occlusive disease first reported by Japanese surgeons in 1957. The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion. It may cause ischemic attacks or cerebral infarction, which is more frequent in children than in adults. In adults, cerebral hemorrhage may occur. The disease is distributed in all age groups, but the highest peak is in childhood at less than 10 years of age. The characteristic histopathologic features of the steno-occlusive arteries are fibrocellular thickening of the intima containing proliferated smooth muscle cells and prominently tortuous and often duplicated internal elastic lamina. There is usually no atheromatous plaque in the arterial wall. Etiology of the disease is still unknown; however, multifactorial inheritance is considered possible because of a higher incidence of the disease in Japanese and Koreans and approximately 10% of familial occurrence among the Japanese. Recent genetic studies suggest some responsible genetic foci in chromosomes 3, 6 and 17.

Entities:  

Mesh:

Year:  2000        PMID: 11037190     DOI: 10.1046/j.1440-1789.2000.00300.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  73 in total

1.  The maya behind moyamoya--the two extremes of the disease.

Authors:  Nandini Vijayakanthi; Thillothammal Natarajan
Journal:  Indian J Pediatr       Date:  2012-06-26       Impact factor: 1.967

2.  Comparative analysis of serum proteomes of moyamoya disease and normal controls.

Authors:  Eun-Jeong Koh; Han-Na Kim; Tian-Ze Ma; Ha-Young Choi; Yong-Geun Kwak
Journal:  J Korean Neurosurg Soc       Date:  2010-07-31

3.  Cerebrovascular disease: New data on surgical therapy for pediatric moyamoya disease.

Authors:  Satoshi Kuroda
Journal:  Nat Rev Neurol       Date:  2010-05       Impact factor: 42.937

Review 4.  Imaging in childhood arterial ischaemic stroke.

Authors:  Brynmor P Jones; Vijya Ganesan; Dawn E Saunders; W Kling Chong
Journal:  Neuroradiology       Date:  2010-05-06       Impact factor: 2.804

5.  Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals.

Authors:  Manu S Goyal; Christopher L Hallemeier; Gregory J Zipfel; Keith M Rich; Robert L Grubb; Michael R Chicoine; Christopher J Moran; DeWitte T Cross; Ralph G Dacey; Colin P Derdeyn
Journal:  Neurosurgery       Date:  2010-08       Impact factor: 4.654

Review 6.  [Pitfalls in mechanical recanalization].

Authors:  R Mühl-Benninghaus
Journal:  Radiologe       Date:  2016-01       Impact factor: 0.635

7.  Intraoperative acute brain swelling when performing indirect anastomosis in a patient with moyamoya disease -A case report-.

Authors:  Ji-Sung Nho; Soo-Eun Choi; Jae-Woo Yi; Jong-Man Kang
Journal:  Korean J Anesthesiol       Date:  2010-12-31

Review 8.  Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Authors:  Jialing Liu; Yongting Wang; Yosuke Akamatsu; Chih Cheng Lee; R Anne Stetler; Michael T Lawton; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2013-11-27       Impact factor: 11.685

9.  A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians.

Authors:  Wanyang Liu; Hirokuni Hashikata; Kayoko Inoue; Norio Matsuura; Yohei Mineharu; Hatasu Kobayashi; Ken-Ichiro Kikuta; Yasushi Takagi; Toshiaki Hitomi; Boris Krischek; Li-Ping Zou; Fang Fang; Roman Herzig; Jeong-Eun Kim; Hyun-Seung Kang; Chang-Wan Oh; David-Alexandre Tregouet; Nobuo Hashimoto; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2009-11-19       Impact factor: 3.674

10.  Cerebrovascular collaterals correlate with disease severity in adult North American patients with Moyamoya disease.

Authors:  M K Strother; M D Anderson; R J Singer; L Du; R D Moore; Y Shyr; T R Ladner; D Arteaga; M A Day; P F Clemmons; M J Donahue
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-20       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.